Jazz Pharmaceuticals Submits New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Source:
    PR Newswire. Jan 22, 2020